ArticlePloS one2021

Disulfiram and copper combination therapy targets NPL4, cancer stem cells and extends survival in a medulloblastoma model.

Riccardo Serra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.